Total Payments
$135,653
2024 Payments
$1,503
Companies
46
Transactions
753
Medicare Patients
3,541
Medicare Billing
$193,856
Payment Breakdown by Category
Other$114,835 (84.7%)
Food & Beverage$10,995 (8.1%)
Travel$9,370 (6.9%)
Education$452.66 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $114,835 | 50 | 84.7% |
| Food and Beverage | $10,995 | 654 | 8.1% |
| Travel and Lodging | $9,370 | 39 | 6.9% |
| Education | $452.66 | 10 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $66,177 | 184 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $62,118 | 158 | $0 (2024) |
| Amgen Inc. | $965.15 | 49 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $953.98 | 54 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $860.28 | 35 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $748.79 | 34 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $400.71 | 20 | $0 (2020) |
| ARALEZ PHARMACEUTICALS US INC. | $278.04 | 29 | $0 (2018) |
| Boston Scientific Corporation | $264.64 | 12 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $252.59 | 17 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,503 | 77 | Amgen Inc. ($322.88) |
| 2023 | $700.01 | 35 | Novartis Pharmaceuticals Corporation ($158.82) |
| 2022 | $158.92 | 9 | Amgen Inc. ($56.64) |
| 2021 | $380.36 | 16 | Amgen Inc. ($134.80) |
| 2020 | $830.38 | 47 | AstraZeneca Pharmaceuticals LP ($116.97) |
| 2019 | $25,166 | 156 | Janssen Pharmaceuticals, Inc ($23,593) |
| 2018 | $46,893 | 190 | Novartis Pharmaceuticals Corporation ($30,244) |
| 2017 | $60,021 | 223 | Novartis Pharmaceuticals Corporation ($31,052) |
All Payment Transactions
753 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: Cardiology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.12 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Cardiology | ||||||
| 11/26/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $42.28 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 11/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/28/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Cardio-renal | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.65 | General |
| Category: Cardiovascular | ||||||
| 10/16/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $141.47 | General |
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.54 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/30/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Cardiology | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Azurity Pharmaceuticals, Inc. | EDARBYCLOR (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/19/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.47 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.56 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 849 | 1,017 | $138,691 | $49,488 |
| 2022 | 12 | 645 | 854 | $124,431 | $46,360 |
| 2021 | 17 | 695 | 805 | $146,675 | $38,371 |
| 2020 | 24 | 1,352 | 1,754 | $208,997 | $59,638 |
Total Patients
3,541
Total Services
4,430
Medicare Billing
$193,856
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 202 | $39,543 | $16,516 | 41.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 158 | 166 | $32,868 | $8,498 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 97 | $12,804 | $5,889 | 46.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 43 | 72 | $9,720 | $4,306 | 44.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $9,999 | $3,911 | 39.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 34 | $8,670 | $3,303 | 38.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 16 | $4,240 | $2,116 | 49.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 25 | 25 | $5,700 | $1,404 | 24.6% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 35 | 38 | $2,888 | $726.13 | 25.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 80 | 115 | $2,990 | $718.90 | 24.0% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 34 | 34 | $2,720 | $648.38 | 23.8% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 62 | 66 | $2,508 | $584.76 | 23.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 29 | 29 | $1,305 | $310.88 | 23.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 30 | $1,680 | $310.34 | 18.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 33 | 33 | $759.00 | $180.84 | 23.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 27 | 27 | $297.00 | $63.72 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 142 | $27,832 | $11,978 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 179 | $23,592 | $10,491 | 44.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 127 | 130 | $25,740 | $6,553 | 25.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 100 | $13,500 | $5,365 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $11,514 | $4,333 | 37.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 31 | 31 | $7,905 | $3,069 | 38.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 15 | $3,975 | $2,002 | 50.4% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2022 | 37 | 39 | $2,964 | $753.58 | 25.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 21 | $1,575 | $621.57 | 39.5% |
About Dr. David Sihau, MD
Dr. David Sihau, MD is a Cardiovascular Disease healthcare provider based in Frankfort, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902864051.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Sihau, MD has received a total of $135,653 in payments from pharmaceutical and medical device companies, with $1,503 received in 2024. These payments were reported across 753 transactions from 46 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($114,835).
As a Medicare-enrolled provider, Sihau has provided services to 3,541 Medicare beneficiaries, totaling 4,430 services with total Medicare billing of $193,856. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Frankfort, KY
- Active Since 05/01/2006
- Last Updated 06/17/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1902864051
Products in Payments
- XARELTO (Drug) $66,359
- ENTRESTO (Drug) $61,933
- LifeVest (Device) $953.98
- Repatha (Biological) $402.88
- MULTAQ (Drug) $393.38
- BRILINTA (Drug) $385.07
- FARXIGA (Drug) $376.21
- Corlanor (Drug) $367.24
- PRALUENT (Drug) $355.41
- PRADAXA (Drug) $285.55
- Vascepa (Drug) $205.66
- ZONTIVITY (Drug) $196.20
- LEQVIO (Drug) $185.42
- ELIQUIS (Drug) $185.36
- PRALUENT (Biological) $163.71
- BYSTOLIC (Drug) $144.32
- Livalo (Drug) $134.17
- JUXTAPID (Drug) $116.18
- JARDIANCE (Drug) $115.16
- Savaysa (Drug) $113.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Frankfort
Raul Heredia, Md, MD
Cardiovascular Disease — Payments: $38,243
Cardiovascular Disease $38,243
Dr. Robert Hammons
Cardiovascular Disease — Payments: $839.68
Cardiovascular Disease $839.68
Grover Tussey, M.d, M.D
Cardiovascular Disease — Payments: $193.96
Cardiovascular Disease $193.96
Dr. Andrew Bustin, Md, MD
Cardiovascular Disease
Cardiovascular Disease